programas cribado cancer
INICIO / CÁNCER COLORRECTAL / ACTUALIZACIÓN BIBLIOGRÁFICA / NOTA BIBLIOGRáFICA CRIBADO C COLORRECTAL 2014-09

Nota bibliográfica cribado c colorrectal 2014-09

Libby G, Brewster DH, Steele RJC. Impact of faecal occult blood test screening on emergency admissions and short-term outcomes for colorectal cancer. Br J Surg. 2014; Available from: http://www.ncbi.nlm.nih.gov/pubmed/25219923. doi: 10.1002/bjs.9613. PMID: 25219923.

CONCLUSION: People who participated in FOBT screening had fewer emergency admissions and a shorter LOS. Deprivation was associated negatively with participation, but the impact of FOBT participation on emergency admissions was independent of deprivation level. The reduction in LOS has potential to reduce financial costs.

Brenner H, Altenhofen L, Stock C, Hoffmeister M. Prevention, Early Detection, and Overdiagnosis of Colorectal Cancer Within 10 Years of Screening Colonoscopy in Germany. Clin Gastroenterol Hepatol. 2014; Available from: http://www.ncbi.nlm.nih.gov/pubmed/25218160. doi: 10.1016/j.cgh.2014.08.036. PMID: 25218160.

CONCLUSIONS: Based on a 10-year analysis of data from a national registry in Germany, screening colonoscopies have large potential for prevention and early detection of CRC, with low risk of overdiagnosis.

Kearns B, Whyte S, Chilcott J, Patnick J. Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening Programme. Br J Cancer. 2014; Available from: http://dx.doi.org/10.1038/bjc.2014.469.

Conclusions: Performance measures for gFOBT screening were generally lower in the repeat screen compared with the initial screen. Screening for CRC using gFOBT is likely to be cost-effective; however, the use of different screening modalities may result in additional benefits. Future economic evaluations of gFOBT should not assume equal sensitivities between screening rounds.

Zorzi M, Senore C, Da Re F, Barca A, Bonelli LA, Cannizzaro R, et al. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy). Gut. 2014; Available from: http://gut.bmj.com/content/early/2014/10/02/gutjnl-2014-307954.abstract. doi: 10.1136/gutjnl-2014-307954.

Conclusions The quality of colonoscopy was affected by patient-related, endoscopist-related and centre-related characteristics. Policies addressing organisational issues should improve the quality of colonoscopy in our programme and similar programmes.

Allison JE, Fraser CG, Halloran SP, Young GP. Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT). Gut Liver. 2014;8(2):117–30. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3964261&tool=pmcentrez&rendertype=abstract. doi: 10.5009/gnl.2014.8.2.117. PMID: 24672652.

 Fecal immunochemical tests for hemoglobin (FIT) are changing the manner in which colorectal cancer (CRC) is screened. Although these tests are being performed worldwide, why is this test different from its predecessors? What evidence supports its adoption? How can this evidence best be used? This review addresses these questions and provides an understanding of FIT theory and practices to expedite international efforts to implement the use of FIT in CRC screening.

Bevan R, Rubin G, Sofianopoulou E, Patnick J, Rees CJ. Implementing a national flexible sigmoidoscopy screening program: results of the English early pilot. Endoscopy. 2014; Available from: http://www.ncbi.nlm.nih.gov/pubmed/25268309. doi: 10.1055/s-0034-1378119. PMID: 25268309.

Conclusion: Delivery of an FSIG screening program to prevent CRC is feasible and should be implemented using a simple invitation system. The national Bowel Scope program subsequently commenced at pilot sites in May 2013, with full implementation planned by 2016
balidea
web desarrollada y mantenida por :